Post-approval studies (Phase 4)Ended earlyNCT01811875
What this trial is testing
Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A
Who this might be right for
Haemophilia A
Bio Products Laboratory 7